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Malignant Mediastinal Tumor with Bone Formation -
Mesothelioma or Sarcoma?
Gunnar Hillerdal, MD*and Go¨ran Elmberger, MD†
Abstract: Mesothelioma can occur in different variants, some of
which are difficult or impossible to differentiate from sarcomas. There
are scattered reports of sarcomatous mesotheliomas that have osteo-
genic properties. Here, we report a 57-year old man who presented with
a mediastinal tumor containing scattered irregular calcifications with
some scattered pleural thickening of the right pleura. Biopsy showed a
sarcoma with bone formation. The man was born in the Turkish village
of Karain, where the incidence of mesothelioma is extremely high, and
a sarcomatous mesothelioma was therefore diagnosed. Since the tumor
was pressing against the large vessels and heart, a debulking was
performed, followed by Pemetrexed and Carboplatin treatment. How-
ever, the tumor grew rapidly and spread to the pleura, involved the
heart, and the patient succumbed. This is to our knowledge the first
report of a sarcomatous mesothelioma with bone formation from
environmental exposure to mineral fibers.
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Malignant mesothelioma is a fairly rare tumor, usuallycaused by exposure to asbestos fibers three or more
decades earlier. This type of tumor is divided into three
subtypes: epitheloid, sarcomatous, and mixed. The sarcoma-
tous type can occur in different variants, some of which are
difficult or impossible to differentiate from true sarcomas.
There are scattered reports in the literature of sarcomatous
mesotheliomas with bone formation.1–6 In Turkey, there are
many reports from villages where environmental exposure to
asbestos has occurred, with a resulting high incidence of
malignant mesotheliomas.7 Another mineral fiber, a fibrous
zeolite called erionite, has an even higher tendency to cause
this tumor,8 and people from some villages, the best known of
which is called Karain, have the highest known death rates in
middle-age due to this tumor. In fact, more than half of
Karain’s present and former inhabitants die from this cause.9
Lately, there have been reports on genetic factors being
important also.10
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FIGURE 1. Mediastinal tumor. (A), frontal view; (B), CT
scan showing the bone formation.
FIGURE 2. Histological section.
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57-year old man presented with a mediastinal tumor
containing scattered irregular calcifications with some scat-
tered pleural thickening of the right pleura (Figure 1). Biopsy
showed a sarcoma with bone formation. He was born in
Karain, Turkey, and lived there for 13 years before he
emigrated to Sweden. He was an former smoker, having
stopped 8 years earlier, and was healthy. Two of his cousins
had died from malignant mesothelioma. In a health investi-
gation he was found to have a high Erythrocyte Sedimenta-
tion Rate, and therefore a chest roentgenogram was per-
formed. He had only slight cough and some slight pain in the
right side.
Large needle biopsy showed a sarcoma with bone
formation (Figure 2). Since the tumor was pressing against
the large vessels and heart, debulking surgery was performed,
removing large pieces of the tumor. The pathologists, despite
extensive immunohistochemistry (Table 1), were still unable
to say whether it was a sarcoma or a sarcomatous mesothe-
lioma with bone formation. The latter diagnosis was sug-
gested by the case history, and after long discussions it was
decided to treat him with Pemetrexed and Carboplatin. He
received two courses, but to no avail; the tumor grew rapidly
and the patient developed a superior vena cava syndrome,
was stented with some improvement, and then developed
heart arrhythmia and succumbed 6 months after diagnosis.
No autopsy was performed.
DISCUSSION
This is to our knowledge the first report of a sarcoma-
tous mesothelioma with bone formation from environmental
exposure to a mineral fiber. The sarcomatous subtype of
mesothelioma has a much worse prognosis than the epitheloid
one, and also less commonly responds to the standard treat-
ment of inoperable mesothelioma, which is a combination of
Pemetrexed and a platinum drug. Other treatment options
were discussed, including radiotherapy, but since the tumor
had spread rapidly and involved the mediastinum and the
right pleura, it was decided that radiotherapy would be
unlikely to benefit the patient.
Different types of mesotheliomas occur. The diagnosis
can be difficult, and we still have no good treatment options
for the sarcomatous subtype. Primary osteosarcomas arising
from the chest wall also occur.11 The diagnosis in this case of
mesothelioma, rather than primary sarcoma, was mainly
based on the patient´s history of living for 13 years in a
village with environmental exposure to erionite and an ex-
tremely high incidence of mesothelioma.7,8,9
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TABLE 1. Immunohistochemistry
Test Result
Ki-67 60% positive for (high proliferative activity)
Vimentin NEGATIVE
NSE Focally POSITIVE
MNF 116 NEGATIVE
CK7 NEGATIVE
CK AE/1/AE3 NEGATIVE
CK18 NEGATIVE
CK20 NEGATIVE
CK high MW NEGATIVE
CK low MW NEGATIVE
HMB45- NEGATIVE
Ostoenctin POSITIVE
EMA A few cells POSITIVE
Actin SM NEGATIVE
Actin HHF35 NEGATIVE
Desmin NEGATIVE
S-100 NEGATIVE
CD15 NEGATIVE
CD34 NEGATIVE
CK 5 NEGATIVE
BerEp4 NEGATIVE
Calretinin NEGATIVE
HBME-1 NEGATIVE
Trombomodulin POSITIVE
NFP POSITIVE
WT-1 NEGATIVE
CEA mono NEGATIVE
CEA poly NEGATIVE
NB84a NEGATIVE
NeuN NEGATIVE
GFAP NEGATIVE
TTF-1 NEGATIVE
P 53 NEGATIVE
Factor XIIIa Some few cells positive
Bcl-2 Weakly POSITIVE
NFP Weakly POSITIVE
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